Apr 06, 2025
Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder
Jul 28, 2024
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder
May 14, 2020
Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening Strategic Presence in Latin America for CNS Business
Apr 23, 2020
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
Mar 27, 2020
Luye Pharma Continues to Deliver Strong Growth in 2019
Feb 10, 2020
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries
Dec 26, 2019
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Sep 03, 2019
The First Asia Pacific Psychiatry Symposium Takes Place
Aug 29, 2019
Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines
Mar 28, 2019
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval
Jan 16, 2019
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field
Dec 30, 2018
Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process
Sep 07, 2018
Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators
Aug 29, 2018
Luye Pharma Releases its Financial Results for the First Half of 2018: Double-Digit Growth in Core Product Sales, Exceeded Expectations in Sales, R&D and M&As
Jul 22, 2018
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China
May 27, 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR